In this study, two cohorts of prevalent HD patients, one treated with expanded hemodialysis therapy enabled by the Theranova dialyzer and the other receiving conventional HD with a high‐flux dialyzer (HF‐HD), were followed up for up to 4 years to determine if there was an association of dialyzer membrane use with variations in serum albumin levels over time. Here, ALB is linked to Huntington disease.